ConductScience.org, home

Paper51344

Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis.

Daniels CA and 1 other. Lancet, 1975. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis. Papers, record 51344. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/51344

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis.
PubMed
Journal
Lancet
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
1.55
iCite
Revised in PubMed
2019-06-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Daniels CAC A
2LeGoff SGS G

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
Herpes LabialisMajor topic
SimplexvirusMajor topic
Antibodies, Anti-Idiotypic
Complement System Proteins
Female
Humans
Male
Neutralization Tests
Recurrence

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
23776340Application and tolerability of Herpotherm(®) in the treatment of genital herpes.Clin Cosmet Investig Dermatol2013https://conductscience.org/library/papers/23776340PubMed
21889905Current management and recommendations for access to antiviral therapy of herpes labialis.J Clin Virol2012https://conductscience.org/library/papers/21889905PubMed
7416235Scanning and transmission electron microscopic studies of complement-mediated lysis and antibody-dependent cell-mediated cytolysis of herpes simplex virus-infected human fibroblasts.Am J Pathol1980https://conductscience.org/library/papers/7416235PubMed
7016915Comparison of fluorescent-antibody, neutralizing-antibody, and complement-enhanced neutralizing-antibody assays for detection of serum antibody to respiratory syncytial virus.J Clin Microbiol1981https://conductscience.org/library/papers/7016915PubMed
6284091Neutralising antibody in mice with primary and recurrent herpes simplex virus infection.Arch Virol1982https://conductscience.org/library/papers/6284091PubMed
6164273Persistent viral infections as models for research in virus chemotherapy.Adv Virus Res1981https://conductscience.org/library/papers/6164273PubMed
1085748Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses.Infect Immun1976https://conductscience.org/library/papers/1085748PubMed
218539Enhanced antiglobulin-mediated neutralization of herpes simplex virus-IgG complexes by complement and heterologous anti-immunoglobulin.Arch Virol1979https://conductscience.org/library/papers/218539PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/51344

GET https://conductscience.org/api/papers/v1/51344/authors